INSULET CORPORATION (PODD) Gross Margin
- Gross margin · 12 months: Value 71.07%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 71.07% | Gross profit / revenue. Period ending 2026-06-30. $2.17B ÷ $3.05B × 100 ≈ 71.07% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 2.17B USD | Gross Profit |
| Revenue | 3.05B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 883.20M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $2.17B | $3.05B | $883.20M | 71.07% |
| 2026-03-31 | $2.06B | $2.90B | $841.00M | 71.01% |
| 2025-12-31 | $1.94B | $2.71B | $768.20M | 71.63% |
| 2025-09-30 | $1.80B | $2.52B | $719.60M | 71.46% |
| 2025-06-30 | $1.67B | $2.36B | $690.20M | 70.75% |
| 2025-03-31 | $1.55B | $2.20B | $651.00M | 70.39% |
| 2024-12-31 | $1.45B | $2.07B | $625.90M | 69.79% |
| 2024-09-30 | $1.38B | $1.98B | $607.90M | 69.36% |
| 2024-06-30 | $1.29B | $1.87B | $580.50M | 69.00% |
| 2024-03-31 | $1.23B | $1.88B | $554.50M | 65.31% |
| 2023-12-31 | $1.16B | $1.70B | $537.20M | 68.35% |
| 2023-09-30 | $1.02B | $1.47B | $541.00M | 69.12% |
| 2023-06-30 | $911.00M | $1.32B | $554.10M | 69.06% |
| 2023-03-31 | $836.40M | $1.07B | $531.60M | 78.19% |
| 2022-12-31 | $805.60M | $1.06B | $499.70M | 76.33% |
| 2022-09-30 | $801.50M | $1.10B | $441.80M | 72.88% |
| 2022-06-30 | $801.90M | $1.08B | $376.20M | 74.27% |
| 2022-03-31 | $794.30M | $1.10B | $347.60M | 72.45% |
| 2021-12-31 | $752.10M | $1.10B | $346.70M | 68.45% |
| 2021-09-30 | $700.00M | $1.04B | $337.20M | 67.49% |
| 2021-06-30 | $663.10M | $995.60M | $332.50M | 66.60% |
| 2021-03-31 | $622.90M | $958.70M | $335.80M | 64.97% |
| 2020-12-31 | $582.30M | $904.40M | $322.10M | 64.39% |
| 2020-09-30 | $555.30M | $867.70M | $312.40M | 64.00% |
| 2020-06-30 | $526.60M | $825.80M | $299.20M | 63.77% |
| 2020-03-31 | $500.50M | $776.60M | $276.10M | 64.45% |
| 2019-12-31 | $480.30M | $738.20M | $257.90M | 65.06% |
| 2019-09-30 | $456.51M | $693.71M | $237.21M | 65.81% |
| 2019-06-30 | $435.39M | $652.67M | $217.28M | 66.71% |
| 2019-03-31 | $401.05M | $599.80M | $198.75M | 66.86% |
| 2018-12-31 | $370.17M | $563.82M | $193.66M | 65.65% |
| 2018-09-30 | $339.36M | $529.44M | $190.08M | 64.10% |
| 2018-06-30 | $311.02M | $500.14M | $189.12M | 62.19% |
| 2018-03-31 | $293.59M | $485.63M | $192.05M | 60.45% |
| 2017-12-31 | $277.17M | $463.77M | $186.60M | 59.76% |
| 2017-09-30 | $258.60M | $436.82M | $178.22M | 59.20% |
| 2017-06-30 | $240.62M | $409.92M | $169.30M | 58.70% |
| 2017-03-31 | $226.43M | $387.49M | $161.06M | 58.44% |
| 2016-12-31 | $211.09M | $366.99M | $155.90M | 57.52% |
| 2016-09-30 | $192.14M | $347.21M | $155.07M | 55.34% |
| 2016-06-30 | $182.95M | $384.07M | $201.12M | 47.64% |
| 2016-03-31 | $163.01M | $357.29M | $194.28M | 45.62% |
| 2015-12-31 | $148.15M | $324.23M | $176.07M | 45.69% |
| 2015-09-30 | $139.51M | $296.67M | $157.16M | 47.02% |
| 2015-06-30 | $141.90M | $284.35M | $142.45M | 49.90% |
| 2015-03-31 | $143.29M | $280.77M | $137.49M | 51.03% |
| 2014-12-31 | $143.29M | $288.72M | $145.43M | 49.63% |
| 2014-09-30 | $139.63M | $284.69M | $145.06M | 49.05% |
| 2014-06-30 | $128.99M | $270.81M | $141.82M | 47.63% |
| 2014-03-31 | $120.05M | $258.89M | $138.84M | 46.37% |
| 2013-12-31 | $112.40M | $247.08M | $134.68M | 45.49% |
| 2013-09-30 | $104.70M | $236.38M | $131.68M | 44.29% |
| 2013-06-30 | $101.70M | $230.03M | $128.33M | 44.21% |
| 2013-03-31 | $97.19M | $220.97M | $123.78M | 43.99% |
| 2012-12-31 | $92.34M | $211.37M | $119.03M | 43.68% |
| 2012-09-30 | $87.10M | $200.73M | $113.64M | 43.39% |
| 2012-06-30 | $81.27M | $190.57M | $109.31M | 42.64% |
| 2012-03-31 | $73.47M | $171.75M | $98.28M | 42.78% |
| 2011-12-31 | $66.71M | $152.25M | $85.54M | 43.82% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | $48.87M | $104.42M | (m) | 46.81% |
| 2010-12-31 | $43.73M | $96.97M | $53.24M | 45.09% |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) |
| 2009-12-31 | $18.30M | $66.03M | $47.73M | 27.71% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |